Endophthalmitis is a serious complication of cataract surgery that every ophthalmic surgeon – and patient – strives to avoid. The visual loss and debilitation that occur in a large proportion of postoperative endophthalmitis cases can be severe and irreversible.
Those most in need of the operation are often those at greatest risk, such as the elderly. Without knowing exactly how, when or why to intervene with effective prophylactic measures, virtually every surgeon today follows a standard of care that involves antisepsis and antibiotics.
Although cataract surgery ranks among the most frequently performed surgical procedures worldwide, data to define the most effective prophylactic measures have been nearly impossible to generate, given the large patient numbers needed to conduct clinical trials. Prevention and elimination of postoperative endophthalmitis, however, is a constant goal of every ophthalmic surgeon.
The clinical practice of administering a direct intracameral injection of cefuroxime at the close of cataract surgery to reduce endophthalmitis rates was first implemented by a group of Swedish surgeons. The clinical benefit of this intervention seemed apparent.
In order to test the hypothesis in a scientific manner, the European Society of Cataract and Refractive Surgeons mounted a large randomized clinical trial to evaluate the intracameral injection in a prospective, randomized fashion across nine European countries.
Results published in 2007 unequivocally demonstrated a clinical benefit, with a five-fold reduction in postoperative endophthalmitis rates in patients who received a 1mg intracameral injection of cefuroxime at the close of cataract surgery.
In the wake of these results, a growing number of centres have adopted this method of prophylaxis, reporting even more striking effects, on occasion, than the ESCRS study itself.
ESCRS members can take thew course now here: https://elearning.escrs.org/course/view.php?id=74
Recorded during the 2016 ESCRS Congress. Free for all to view. Full course schedule below video
ESCRS 2007 Congress
ESCRS 2012 Congress. ESCRS on Demand
|Jun 2007||JCRS Article June 2007: Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors|
The landmark article from the ESCRS Endophthalmitis Study Group. This article has now been cited over 600 times.
|Jun 2002||JCRS Article June 2002: Prophylactic intracameral cefuroxime: Evaluation of safety and kinetics in cataract surgery|
Per Montan et al. To evaluate the safety and kinetics of prophylactic intracameral cefuroxime in cataract surgery.
|Jun 2002||JCRS Article June 2002: Prophylactic intracameral cefuroxime: Efficacy in preventing endophthalmitis after cataract surgery|
Per Montan et al. Presented at the XVIth Congress of the European Society of Cataract & Refractive Surgeons, Nice, France, September 1998, the XIIth meeting of the European Society of Ophthalmology, Stockholm, Sweden, June 1999, and the XIIIth meeting of the European Society of Ophthalmology, Istanbul, Turkey, June 2001.
|Jan 2014||JCRS Article January 2014: Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: Update on the ESCRS Endophthalmitis Study|
An update on the original landmark 2007 study
|Aug 2018||JCRS Article September 2013: Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns in 9 European countries|
Data on practice patterns for prophylaxis against infectious postoperative endophthalmitis (IPOE) during cataract surgery in 9 European countries were searched in national registers and reviews of published surveys. Summary reports assessed each nation’s IPOE rates, nonantibiotic prophylactic routines, topical and intracameral antibiotic use, and coherence to the European Society of Cataract & Refractive Surgeons (ESCRS) 2007 guidelines.
|Aug 2018||JCRS Article September 2009: Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery|
This article showed that swollen lids, pain, and an opaque vitreous were statistically associated with proven endophthalmitis cases in the ESCRS study.
|Aug 2018||JCRS Article April 2009: United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study|
The European Society of Cataract & Refractive Surgeons Endophthalmitis Study published preliminary results in 2006 showing a near 5-fold decrease in the rates of postoperative endophthalmitis with the use of intracameral cefuroxime. The study findings have generated considerable controversy, and 1 year later its recommendations had been heeded by only 6% of American Society of […]
|Aug 2018||JCRS October 2007: Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: Potential role of moxifloxacin|
To aid the cataract surgeon’s understanding of rational approaches to antimicrobial prophylaxis and place the European Society of Cataract & Refractive Surgeons (ESCRS) postoperative endophthalmitis study in perspective, a review was conducted of published and unpublished data on intracameral antibiotic use during cataract surgery and the antimicrobial efficacy, pharmacodynamics, ocular penetration, and safety of moxifloxacin. […]
|Aug 2018||JCRS Article March 2006: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study|
One of the original arguments for adopting a multicenter study to investigate prophylaxis of postoperative endophthalmitis after cataract surgery:
|Project Leader||Project Amount||Title||Status|
|Dr. Jan Willem Beenakker The Netherlands||€650,195||Virtual Refractive Surgery for the Prevention Of Negative Dysphotopsia (“vRESPOND”)||COMPLETED||View study|
|Joaquim Carlos Neto Murta Portugal||€306,071||NECSUS-Neuroadaptation after Cataract and Refractive Surgery Study||COMPLETED||View study|
|Prof. Oliver Findl Austria||€549,643||Influence of posterior vitreous detachment on retinal detachment after lens surgery in myopic eyes (MYOPRED)||IN PROGRESS||View study|
|Nineke Visser The Netherlands||€749,707||The EPICAT study: Effectiveness of Periocular drug Injection in CATaract surgery||IN PROGRESS||View study|
|Mayank Nanavaty UK||€72,965.88||MERoV: the Monofocal Extended Range of Vision Study||IN PROGRESS||View study|
|Gary P. Misson UK||€29,780||Cataract, age related Macular degeneration and Polarization perception: the “CaMPoL Study”||IN PROGRESS||View study|
|Rudy Nuijts The Netherlands||—||PREvention of Macular EDema after cataract surgery (PREMED) Study Portal||COMPLETED||View study|
|Peter Barry Ireland||—||Endophthalmitis Study Portal||COMPLETED||View study|